Roll up for China versus OMICRON

Advertisement

Roll up for China versus OMICRON:

Covid cases continue to surge as Omicron strengthens its grip on the Chinese mainland. Hong Kong provides a grim preview of what could unfold in China if the outbreaks are not brought under control.

Both territories have relatively low vaccination rates amongst the elderly, and in Hong Kong’s case this is resulting in case fatality rates higher than those in the UK at the start of the pandemic. The healthcare system is buckling. China’s would fare worse, given lower per capita healthcare spending.

The full text of this article is available to MacroBusiness subscribers

$1 for your first month, then:
Cancel at any time through our billing provider, Stripe
About the author
David Llewellyn-Smith is Chief Strategist at the MB Fund and MB Super. David is the founding publisher and editor of MacroBusiness and was the founding publisher and global economy editor of The Diplomat, the Asia Pacific’s leading geo-politics and economics portal. He is also a former gold trader and economic commentator at The Sydney Morning Herald, The Age, the ABC and Business Spectator. He is the co-author of The Great Crash of 2008 with Ross Garnaut and was the editor of the second Garnaut Climate Change Review.